| pubmed-article:9740232 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0015880 | lld:lifeskim |
| pubmed-article:9740232 | lifeskim:mentions | umls-concept:C0162568 | lld:lifeskim |
| pubmed-article:9740232 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9740232 | pubmed:dateCreated | 1998-10-2 | lld:pubmed |
| pubmed-article:9740232 | pubmed:abstractText | Erythropoietic protoporphyria is a hereditary disorder of porphyrin metabolism caused by mutations in the ferrochelatase gene. Ferrochelatase catalyzes the chelation of ferrous iron into protoporphyrin IX to form heme. Mutation analysis was performed in four Spanish erythropoietic protoporphyria families resulting in the identification of four different mutations in the ferrochelatase gene. Two of them were novel mutations, a missense mutation (1157 A-->C, H386P) and a frameshift mutation (843delC) found in two Spanish families, respectively. The third and the forth Spanish patients carried already published ferrochelatase gene mutations, a nonsense mutation (343C-->T, R115X) and a missense mutation (557T-->C, I186T), respectively. The newly described frameshift mutation (843delC) predicted formation of an abrupt mRNA. The deleterious effect of His386 to Pro substitution as a result of mutation 1157 A-->C on the ferrochelatase activity was investigated by expressing the mutant ferrochelatase in Escherichia coli. The mutant ferrochelatase exhibited only 0.8% of the wild-type ferrochelatase activity. Prediction of the secondary structure of ferrochelatase suggested that the H386P mutation disrupted the original alpha-helical structure by way of introducing a turn, a rather drastic structural change of the enzyme sufficient to cause activity loss. | lld:pubmed |
| pubmed-article:9740232 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9740232 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9740232 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9740232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9740232 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9740232 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9740232 | pubmed:issn | 0022-202X | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:MinderE IEI | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:MascaroJ MJM | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:HerreroCC | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:LechaMM | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:PuyHH | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:DeybachJ CJC | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:Schneider-Yin... | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:GouyaLL | lld:pubmed |
| pubmed-article:9740232 | pubmed:author | pubmed-author:RüfenachtUU | lld:pubmed |
| pubmed-article:9740232 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9740232 | pubmed:volume | 111 | lld:pubmed |
| pubmed-article:9740232 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9740232 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9740232 | pubmed:pagination | 406-9 | lld:pubmed |
| pubmed-article:9740232 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:meshHeading | pubmed-meshheading:9740232-... | lld:pubmed |
| pubmed-article:9740232 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9740232 | pubmed:articleTitle | Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria. | lld:pubmed |
| pubmed-article:9740232 | pubmed:affiliation | Center Francais des Porphyries, INSERM, Hopital Louis Mourier, Colombes, France. | lld:pubmed |
| pubmed-article:9740232 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9740232 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| literatureCitation:1591_974... | literatureCitation:pubmed | pubmed-article:9740232 | lld:drugbank |
| entrez-gene:2235 | entrezgene:pubmed | pubmed-article:9740232 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9740232 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9740232 | lld:pubmed |
